MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 50 filers reported holding MIRATI THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.35 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,623,000 | +50.7% | 175,000 | +25.0% | 0.82% | +54.2% |
| Q2 2023 | $5,058,200 | -35.9% | 140,000 | -34.9% | 0.53% | -38.5% |
| Q1 2023 | $7,888,350 | -42.0% | 215,000 | -28.3% | 0.87% | -38.9% |
| Q4 2022 | $13,593,000 | +2.5% | 300,000 | +52.2% | 1.42% | +2.1% |
| Q3 2022 | $13,267,000 | +4.0% | 197,067 | +3.7% | 1.39% | -4.1% |
| Q2 2022 | $12,755,000 | +3.6% | 190,000 | +26.8% | 1.45% | +19.3% |
| Q1 2022 | $12,317,000 | -44.6% | 149,800 | -0.1% | 1.22% | -17.8% |
| Q4 2021 | $22,235,000 | -16.2% | 150,000 | 0.0% | 1.48% | -20.6% |
| Q3 2021 | $26,537,000 | -0.4% | 150,000 | -9.1% | 1.86% | +3.0% |
| Q2 2021 | $26,652,000 | +3.7% | 165,000 | +10.0% | 1.81% | +0.9% |
| Q1 2021 | $25,695,000 | +17.0% | 150,000 | +50.0% | 1.79% | 0.0% |
| Q4 2020 | $21,964,000 | +15.7% | 100,000 | -12.5% | 1.79% | +6.2% |
| Q3 2020 | $18,981,000 | +66.3% | 114,311 | +14.3% | 1.69% | +36.9% |
| Q2 2020 | $11,417,000 | +14.2% | 100,000 | -23.1% | 1.23% | -11.9% |
| Q1 2020 | $9,993,000 | -38.0% | 130,000 | +4.0% | 1.40% | -20.7% |
| Q4 2019 | $16,108,000 | +106.8% | 125,000 | +25.0% | 1.76% | +80.7% |
| Q3 2019 | $7,791,000 | -58.4% | 100,000 | -45.1% | 0.98% | -52.7% |
| Q2 2019 | $18,747,000 | +101.2% | 182,008 | +43.2% | 2.06% | +89.4% |
| Q1 2019 | $9,316,000 | +158.3% | 127,093 | +49.5% | 1.09% | +164.6% |
| Q4 2018 | $3,606,000 | +1870.5% | 85,000 | +70.0% | 0.41% | +1484.6% |
| Q2 2017 | $183,000 | -29.6% | 50,000 | 0.0% | 0.03% | -36.6% |
| Q1 2017 | $260,000 | +9.2% | 50,000 | 0.0% | 0.04% | -10.9% |
| Q4 2016 | $238,000 | -99.9% | 50,000 | 0.0% | 0.05% | -11.5% |
| Q3 2016 | $330,500,000 | +120962.3% | 50,000 | 0.0% | 0.05% | +8.3% |
| Q2 2016 | $273,000 | -74.5% | 50,000 | 0.0% | 0.05% | -77.4% |
| Q1 2016 | $1,070,000 | -32.3% | 50,000 | 0.0% | 0.21% | -11.3% |
| Q4 2015 | $1,580,000 | -8.2% | 50,000 | 0.0% | 0.24% | -12.8% |
| Q3 2015 | $1,721,000 | +9.3% | 50,000 | 0.0% | 0.27% | +45.0% |
| Q2 2015 | $1,574,000 | +18.3% | 50,000 | +10.2% | 0.19% | -15.6% |
| Q1 2015 | $1,331,000 | – | 45,388 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |